Indirubin-3′-monoxime Inhibits Β-Amyloid-induced Neurotoxicity in Neuroblastoma SH-SY5Y Cells

Shugang Zhang,Yingdong Zhang,Ligang Xu,Xingjian Lin,Jie Lu,Qing Di,Jingping Shi,Jun Xu
DOI: https://doi.org/10.1016/j.neulet.2008.11.030
IF: 3.197
2009-01-01
Neuroscience Letters
Abstract:Increasing evidence suggests that the inappropriate activation of cyclin-dependent kinases (CDKs) could induce neuronal apoptosis in Alzheimer's disease (AD), which means that the pharmacological inhibitors of cell-cycle progression may effectively impede the development or progression of AD. Indirubin-3′-monoxime (IMX), a known effective inhibitor of CDKs, has been shown to have therapeutic effects on learning and memory deficits induced by beta-amyloid (Aβ) intracerebroventricular infusion in rats. In the present study, we investigated the neuroprotective effects of IMX on Aβ25–35-induced neuronal apoptosis and its potential mechanisms in human neuroblastoma SH-SY5Y cells. Aβ25–35-induced apoptosis, characterized by decreased cell viability, neuronal DNA condensation, and fragmentation, was associated with an increase in tau protein hyperphosphorylation. IMX, however, attenuated Aβ25–35-induced cell death in a dose-dependent manner. Furthermore, expression of hyperphosphorylation tau protein was significantly decreased with IMX treatment. Our study suggests that IMX may usefully prevent or delay the neuronal loss of AD.
What problem does this paper attempt to address?